N-methyl-d,l-aspartate modulation of pituitary hormone secretion in the pig: Role of opioid peptides

Sixteen ovariectomized (OVX) mature gilts, averaging 139.6 ± 3.1 kg body weight (BW) were assigned randomly to receive either progesterone (P, 0.85 mg/kg BW, n=8) or corn oil vehicle (OIL, n=8) injections im twice daily for 10 d. On the day of experiment, all gilts received either the EAA agonist, N...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Domestic animal endocrinology 1993-10, Vol.10 (4), p.305-313
Hauptverfasser: Chang, W.J., Barb, C.R., Kraeling, R.R., Rampacek, G.B., Asanovich, K.M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 313
container_issue 4
container_start_page 305
container_title Domestic animal endocrinology
container_volume 10
creator Chang, W.J.
Barb, C.R.
Kraeling, R.R.
Rampacek, G.B.
Asanovich, K.M.
description Sixteen ovariectomized (OVX) mature gilts, averaging 139.6 ± 3.1 kg body weight (BW) were assigned randomly to receive either progesterone (P, 0.85 mg/kg BW, n=8) or corn oil vehicle (OIL, n=8) injections im twice daily for 10 d. On the day of experiment, all gilts received either the EAA agonist, N-methyl-d,l-aspartate (NMA; 10 mg/kg BW, iv) alone or NMA plus the EOP antagonist, naloxone (NAL, 1 mg/kg BW, iv), resulting in the following groups of 4 gilts each: OIL-NMA, OIL-NMA-NAL, P-NMA and P-NMA-NAL. Blood samples were collected via jugular cannula every 15 min for 6 hr. All pigs received NMA 5 min following pretreatment with either 0.9% saline or NAL 2 hr after blood collection began and a GnRH challenge 3 hr after NMA. Administration of NMA suppressed (P
doi_str_mv 10.1016/0739-7240(93)90034-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76213387</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0739724093900349</els_id><sourcerecordid>76213387</sourcerecordid><originalsourceid>FETCH-LOGICAL-c376t-1d423d18936f75ebe0d0439753993f0427b8416c4c9e9781f34e1343db1cade53</originalsourceid><addsrcrecordid>eNp9kNFKHDEUQINU7Lr1B0oL81QUmprMzSaTPhREtC1IC7Y-h2xyx02ZmUyTjODfO-suPvqUwDn3hhxCPnD2hTMuz5kCTVUt2KmGM80YCKoPyII3SlPGVuINWbwob8lxzv8YY2oePSJHDTApQSyI_0V7LJvHjvrPHbV5tKnYglUf_dTZEuJQxbYaQ5lCsemx2sTUxwGrjC7hMw5DVTY4K_dfq9vY4daPY4jBVyOOJXjM78hha7uMJ_tzSe6ur_5e_qA3v7__vLy4oQ6ULJR7UYPnjQbZqhWukXkmQKsVaA0tE7VaN4JLJ5xGrRregkAOAvyaO-txBUvyabd3TPH_hLmYPmSHXWcHjFM2StYcoFGzKHaiSzHnhK0ZU-jn_xnOzDau2ZYz23JGg3mOO1-W5ON-_7Tu0b8M7WvO_P2OtzYae59CNnd_tKgbKdkMv-0gzgUeAiaTXcDBoQ8JXTE-htdffwKKKpDa</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76213387</pqid></control><display><type>article</type><title>N-methyl-d,l-aspartate modulation of pituitary hormone secretion in the pig: Role of opioid peptides</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Chang, W.J. ; Barb, C.R. ; Kraeling, R.R. ; Rampacek, G.B. ; Asanovich, K.M.</creator><creatorcontrib>Chang, W.J. ; Barb, C.R. ; Kraeling, R.R. ; Rampacek, G.B. ; Asanovich, K.M.</creatorcontrib><description><![CDATA[Sixteen ovariectomized (OVX) mature gilts, averaging 139.6 ± 3.1 kg body weight (BW) were assigned randomly to receive either progesterone (P, 0.85 mg/kg BW, n=8) or corn oil vehicle (OIL, n=8) injections im twice daily for 10 d. On the day of experiment, all gilts received either the EAA agonist, N-methyl-d,l-aspartate (NMA; 10 mg/kg BW, iv) alone or NMA plus the EOP antagonist, naloxone (NAL, 1 mg/kg BW, iv), resulting in the following groups of 4 gilts each: OIL-NMA, OIL-NMA-NAL, P-NMA and P-NMA-NAL. Blood samples were collected via jugular cannula every 15 min for 6 hr. All pigs received NMA 5 min following pretreatment with either 0.9% saline or NAL 2 hr after blood collection began and a GnRH challenge 3 hr after NMA. Administration of NMA suppressed (P<0.03) LH secretion in OIL-NMA gilts and treatment with NAL failed to reverse the suppressive effect of NMA on LH secretion in OIL-NMA-NAL gilts. Similar to OIL-NMA gilts, NMA decreased (P<0.03) mean serum LH concentrations in P-NMA gilts. However, in P-NMA-NAL gilts, serum LH concentrations were not changed following treatment. All gilts responded to GnRH with increased (P<0.01) LH secretion. Additionally, administration of NMA increased (P<0.01) growth hormone (GH) and prolactin (PRL) secretion in both OIL-NMA and P-NMA gilts, but this increase in GH and PRL secretion was attenuated (P<0.01) by pretreatment with NAL in OIL-NMA-NAL and P-NMA-NAL gilts. Serum cortisol concentrations increased (P<0.01) in all gilts and the magnitude of the cortisol response was not different among groups. In summary, results of the present study confirmed previous findings that NMA suppresses LH secretion in both oil- and P-treated OVX gilts, but we failed to provide definitive evidence that EOP are involved in the NMA-induced suppression of LH secretion. However, NMA may, in part, activate the EOP system which in turn increased GH and PRL secretion in the gilt.]]></description><identifier>ISSN: 0739-7240</identifier><identifier>EISSN: 1879-0054</identifier><identifier>DOI: 10.1016/0739-7240(93)90034-9</identifier><identifier>PMID: 8306634</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>ACIDE AMINE ; AMINO ACIDS ; AMINOACIDOS ; Analysis of Variance ; Animals ; ANTIMETABOLITE ; ANTIMETABOLITES ; ANTIMETABOLITOS ; BLOOD SAMPLING ; CERDAS ; Endorphins - physiology ; ESTEROIDES ; EXCITATORY AMINO ACIDS ; Female ; FEMALES ; FEMELLE ; GILTS ; GLANDULA PITUITARIA ; Growth Hormone - secretion ; HEMBRA ; HORMONAS ; HORMONE ; HORMONES ; HYDROCORTISONE ; Hydrocortisone - secretion ; HYPOPHYSE ; Luteinizing Hormone - secretion ; MUESTREO SANGUINEO ; N-Methylaspartate - pharmacology ; Naloxone - pharmacology ; OVARIECTOMIA ; OVARIECTOMIE ; OVARIECTOMY ; PEPTIDE ; PEPTIDES ; PEPTIDOS ; PITUITARY GLAND ; Pituitary Gland - drug effects ; Pituitary Gland - secretion ; Pituitary Hormones - secretion ; PRELEVEMENT SANGUIN ; PROGESTERONA ; PROGESTERONE ; Progesterone - pharmacology ; PROLACTIN ; Prolactin - secretion ; PROLACTINA ; PROLACTINE ; Radioimmunoassay ; Random Allocation ; SECRECION ; SECRETION ; SOMATOTROPIN ; SOMATOTROPINA ; SOMATOTROPINE ; SOWS ; STEROIDE ; STEROIDS ; Swine - metabolism ; Time Factors ; TRUIE</subject><ispartof>Domestic animal endocrinology, 1993-10, Vol.10 (4), p.305-313</ispartof><rights>1993</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c376t-1d423d18936f75ebe0d0439753993f0427b8416c4c9e9781f34e1343db1cade53</citedby><cites>FETCH-LOGICAL-c376t-1d423d18936f75ebe0d0439753993f0427b8416c4c9e9781f34e1343db1cade53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0739724093900349$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8306634$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, W.J.</creatorcontrib><creatorcontrib>Barb, C.R.</creatorcontrib><creatorcontrib>Kraeling, R.R.</creatorcontrib><creatorcontrib>Rampacek, G.B.</creatorcontrib><creatorcontrib>Asanovich, K.M.</creatorcontrib><title>N-methyl-d,l-aspartate modulation of pituitary hormone secretion in the pig: Role of opioid peptides</title><title>Domestic animal endocrinology</title><addtitle>Domest Anim Endocrinol</addtitle><description><![CDATA[Sixteen ovariectomized (OVX) mature gilts, averaging 139.6 ± 3.1 kg body weight (BW) were assigned randomly to receive either progesterone (P, 0.85 mg/kg BW, n=8) or corn oil vehicle (OIL, n=8) injections im twice daily for 10 d. On the day of experiment, all gilts received either the EAA agonist, N-methyl-d,l-aspartate (NMA; 10 mg/kg BW, iv) alone or NMA plus the EOP antagonist, naloxone (NAL, 1 mg/kg BW, iv), resulting in the following groups of 4 gilts each: OIL-NMA, OIL-NMA-NAL, P-NMA and P-NMA-NAL. Blood samples were collected via jugular cannula every 15 min for 6 hr. All pigs received NMA 5 min following pretreatment with either 0.9% saline or NAL 2 hr after blood collection began and a GnRH challenge 3 hr after NMA. Administration of NMA suppressed (P<0.03) LH secretion in OIL-NMA gilts and treatment with NAL failed to reverse the suppressive effect of NMA on LH secretion in OIL-NMA-NAL gilts. Similar to OIL-NMA gilts, NMA decreased (P<0.03) mean serum LH concentrations in P-NMA gilts. However, in P-NMA-NAL gilts, serum LH concentrations were not changed following treatment. All gilts responded to GnRH with increased (P<0.01) LH secretion. Additionally, administration of NMA increased (P<0.01) growth hormone (GH) and prolactin (PRL) secretion in both OIL-NMA and P-NMA gilts, but this increase in GH and PRL secretion was attenuated (P<0.01) by pretreatment with NAL in OIL-NMA-NAL and P-NMA-NAL gilts. Serum cortisol concentrations increased (P<0.01) in all gilts and the magnitude of the cortisol response was not different among groups. In summary, results of the present study confirmed previous findings that NMA suppresses LH secretion in both oil- and P-treated OVX gilts, but we failed to provide definitive evidence that EOP are involved in the NMA-induced suppression of LH secretion. However, NMA may, in part, activate the EOP system which in turn increased GH and PRL secretion in the gilt.]]></description><subject>ACIDE AMINE</subject><subject>AMINO ACIDS</subject><subject>AMINOACIDOS</subject><subject>Analysis of Variance</subject><subject>Animals</subject><subject>ANTIMETABOLITE</subject><subject>ANTIMETABOLITES</subject><subject>ANTIMETABOLITOS</subject><subject>BLOOD SAMPLING</subject><subject>CERDAS</subject><subject>Endorphins - physiology</subject><subject>ESTEROIDES</subject><subject>EXCITATORY AMINO ACIDS</subject><subject>Female</subject><subject>FEMALES</subject><subject>FEMELLE</subject><subject>GILTS</subject><subject>GLANDULA PITUITARIA</subject><subject>Growth Hormone - secretion</subject><subject>HEMBRA</subject><subject>HORMONAS</subject><subject>HORMONE</subject><subject>HORMONES</subject><subject>HYDROCORTISONE</subject><subject>Hydrocortisone - secretion</subject><subject>HYPOPHYSE</subject><subject>Luteinizing Hormone - secretion</subject><subject>MUESTREO SANGUINEO</subject><subject>N-Methylaspartate - pharmacology</subject><subject>Naloxone - pharmacology</subject><subject>OVARIECTOMIA</subject><subject>OVARIECTOMIE</subject><subject>OVARIECTOMY</subject><subject>PEPTIDE</subject><subject>PEPTIDES</subject><subject>PEPTIDOS</subject><subject>PITUITARY GLAND</subject><subject>Pituitary Gland - drug effects</subject><subject>Pituitary Gland - secretion</subject><subject>Pituitary Hormones - secretion</subject><subject>PRELEVEMENT SANGUIN</subject><subject>PROGESTERONA</subject><subject>PROGESTERONE</subject><subject>Progesterone - pharmacology</subject><subject>PROLACTIN</subject><subject>Prolactin - secretion</subject><subject>PROLACTINA</subject><subject>PROLACTINE</subject><subject>Radioimmunoassay</subject><subject>Random Allocation</subject><subject>SECRECION</subject><subject>SECRETION</subject><subject>SOMATOTROPIN</subject><subject>SOMATOTROPINA</subject><subject>SOMATOTROPINE</subject><subject>SOWS</subject><subject>STEROIDE</subject><subject>STEROIDS</subject><subject>Swine - metabolism</subject><subject>Time Factors</subject><subject>TRUIE</subject><issn>0739-7240</issn><issn>1879-0054</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kNFKHDEUQINU7Lr1B0oL81QUmprMzSaTPhREtC1IC7Y-h2xyx02ZmUyTjODfO-suPvqUwDn3hhxCPnD2hTMuz5kCTVUt2KmGM80YCKoPyII3SlPGVuINWbwob8lxzv8YY2oePSJHDTApQSyI_0V7LJvHjvrPHbV5tKnYglUf_dTZEuJQxbYaQ5lCsemx2sTUxwGrjC7hMw5DVTY4K_dfq9vY4daPY4jBVyOOJXjM78hha7uMJ_tzSe6ur_5e_qA3v7__vLy4oQ6ULJR7UYPnjQbZqhWukXkmQKsVaA0tE7VaN4JLJ5xGrRregkAOAvyaO-txBUvyabd3TPH_hLmYPmSHXWcHjFM2StYcoFGzKHaiSzHnhK0ZU-jn_xnOzDau2ZYz23JGg3mOO1-W5ON-_7Tu0b8M7WvO_P2OtzYae59CNnd_tKgbKdkMv-0gzgUeAiaTXcDBoQ8JXTE-htdffwKKKpDa</recordid><startdate>19931001</startdate><enddate>19931001</enddate><creator>Chang, W.J.</creator><creator>Barb, C.R.</creator><creator>Kraeling, R.R.</creator><creator>Rampacek, G.B.</creator><creator>Asanovich, K.M.</creator><general>Elsevier Inc</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19931001</creationdate><title>N-methyl-d,l-aspartate modulation of pituitary hormone secretion in the pig: Role of opioid peptides</title><author>Chang, W.J. ; Barb, C.R. ; Kraeling, R.R. ; Rampacek, G.B. ; Asanovich, K.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c376t-1d423d18936f75ebe0d0439753993f0427b8416c4c9e9781f34e1343db1cade53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>ACIDE AMINE</topic><topic>AMINO ACIDS</topic><topic>AMINOACIDOS</topic><topic>Analysis of Variance</topic><topic>Animals</topic><topic>ANTIMETABOLITE</topic><topic>ANTIMETABOLITES</topic><topic>ANTIMETABOLITOS</topic><topic>BLOOD SAMPLING</topic><topic>CERDAS</topic><topic>Endorphins - physiology</topic><topic>ESTEROIDES</topic><topic>EXCITATORY AMINO ACIDS</topic><topic>Female</topic><topic>FEMALES</topic><topic>FEMELLE</topic><topic>GILTS</topic><topic>GLANDULA PITUITARIA</topic><topic>Growth Hormone - secretion</topic><topic>HEMBRA</topic><topic>HORMONAS</topic><topic>HORMONE</topic><topic>HORMONES</topic><topic>HYDROCORTISONE</topic><topic>Hydrocortisone - secretion</topic><topic>HYPOPHYSE</topic><topic>Luteinizing Hormone - secretion</topic><topic>MUESTREO SANGUINEO</topic><topic>N-Methylaspartate - pharmacology</topic><topic>Naloxone - pharmacology</topic><topic>OVARIECTOMIA</topic><topic>OVARIECTOMIE</topic><topic>OVARIECTOMY</topic><topic>PEPTIDE</topic><topic>PEPTIDES</topic><topic>PEPTIDOS</topic><topic>PITUITARY GLAND</topic><topic>Pituitary Gland - drug effects</topic><topic>Pituitary Gland - secretion</topic><topic>Pituitary Hormones - secretion</topic><topic>PRELEVEMENT SANGUIN</topic><topic>PROGESTERONA</topic><topic>PROGESTERONE</topic><topic>Progesterone - pharmacology</topic><topic>PROLACTIN</topic><topic>Prolactin - secretion</topic><topic>PROLACTINA</topic><topic>PROLACTINE</topic><topic>Radioimmunoassay</topic><topic>Random Allocation</topic><topic>SECRECION</topic><topic>SECRETION</topic><topic>SOMATOTROPIN</topic><topic>SOMATOTROPINA</topic><topic>SOMATOTROPINE</topic><topic>SOWS</topic><topic>STEROIDE</topic><topic>STEROIDS</topic><topic>Swine - metabolism</topic><topic>Time Factors</topic><topic>TRUIE</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, W.J.</creatorcontrib><creatorcontrib>Barb, C.R.</creatorcontrib><creatorcontrib>Kraeling, R.R.</creatorcontrib><creatorcontrib>Rampacek, G.B.</creatorcontrib><creatorcontrib>Asanovich, K.M.</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Domestic animal endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, W.J.</au><au>Barb, C.R.</au><au>Kraeling, R.R.</au><au>Rampacek, G.B.</au><au>Asanovich, K.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>N-methyl-d,l-aspartate modulation of pituitary hormone secretion in the pig: Role of opioid peptides</atitle><jtitle>Domestic animal endocrinology</jtitle><addtitle>Domest Anim Endocrinol</addtitle><date>1993-10-01</date><risdate>1993</risdate><volume>10</volume><issue>4</issue><spage>305</spage><epage>313</epage><pages>305-313</pages><issn>0739-7240</issn><eissn>1879-0054</eissn><abstract><![CDATA[Sixteen ovariectomized (OVX) mature gilts, averaging 139.6 ± 3.1 kg body weight (BW) were assigned randomly to receive either progesterone (P, 0.85 mg/kg BW, n=8) or corn oil vehicle (OIL, n=8) injections im twice daily for 10 d. On the day of experiment, all gilts received either the EAA agonist, N-methyl-d,l-aspartate (NMA; 10 mg/kg BW, iv) alone or NMA plus the EOP antagonist, naloxone (NAL, 1 mg/kg BW, iv), resulting in the following groups of 4 gilts each: OIL-NMA, OIL-NMA-NAL, P-NMA and P-NMA-NAL. Blood samples were collected via jugular cannula every 15 min for 6 hr. All pigs received NMA 5 min following pretreatment with either 0.9% saline or NAL 2 hr after blood collection began and a GnRH challenge 3 hr after NMA. Administration of NMA suppressed (P<0.03) LH secretion in OIL-NMA gilts and treatment with NAL failed to reverse the suppressive effect of NMA on LH secretion in OIL-NMA-NAL gilts. Similar to OIL-NMA gilts, NMA decreased (P<0.03) mean serum LH concentrations in P-NMA gilts. However, in P-NMA-NAL gilts, serum LH concentrations were not changed following treatment. All gilts responded to GnRH with increased (P<0.01) LH secretion. Additionally, administration of NMA increased (P<0.01) growth hormone (GH) and prolactin (PRL) secretion in both OIL-NMA and P-NMA gilts, but this increase in GH and PRL secretion was attenuated (P<0.01) by pretreatment with NAL in OIL-NMA-NAL and P-NMA-NAL gilts. Serum cortisol concentrations increased (P<0.01) in all gilts and the magnitude of the cortisol response was not different among groups. In summary, results of the present study confirmed previous findings that NMA suppresses LH secretion in both oil- and P-treated OVX gilts, but we failed to provide definitive evidence that EOP are involved in the NMA-induced suppression of LH secretion. However, NMA may, in part, activate the EOP system which in turn increased GH and PRL secretion in the gilt.]]></abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>8306634</pmid><doi>10.1016/0739-7240(93)90034-9</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0739-7240
ispartof Domestic animal endocrinology, 1993-10, Vol.10 (4), p.305-313
issn 0739-7240
1879-0054
language eng
recordid cdi_proquest_miscellaneous_76213387
source MEDLINE; Elsevier ScienceDirect Journals
subjects ACIDE AMINE
AMINO ACIDS
AMINOACIDOS
Analysis of Variance
Animals
ANTIMETABOLITE
ANTIMETABOLITES
ANTIMETABOLITOS
BLOOD SAMPLING
CERDAS
Endorphins - physiology
ESTEROIDES
EXCITATORY AMINO ACIDS
Female
FEMALES
FEMELLE
GILTS
GLANDULA PITUITARIA
Growth Hormone - secretion
HEMBRA
HORMONAS
HORMONE
HORMONES
HYDROCORTISONE
Hydrocortisone - secretion
HYPOPHYSE
Luteinizing Hormone - secretion
MUESTREO SANGUINEO
N-Methylaspartate - pharmacology
Naloxone - pharmacology
OVARIECTOMIA
OVARIECTOMIE
OVARIECTOMY
PEPTIDE
PEPTIDES
PEPTIDOS
PITUITARY GLAND
Pituitary Gland - drug effects
Pituitary Gland - secretion
Pituitary Hormones - secretion
PRELEVEMENT SANGUIN
PROGESTERONA
PROGESTERONE
Progesterone - pharmacology
PROLACTIN
Prolactin - secretion
PROLACTINA
PROLACTINE
Radioimmunoassay
Random Allocation
SECRECION
SECRETION
SOMATOTROPIN
SOMATOTROPINA
SOMATOTROPINE
SOWS
STEROIDE
STEROIDS
Swine - metabolism
Time Factors
TRUIE
title N-methyl-d,l-aspartate modulation of pituitary hormone secretion in the pig: Role of opioid peptides
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T08%3A14%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=N-methyl-d,l-aspartate%20modulation%20of%20pituitary%20hormone%20secretion%20in%20the%20pig:%20Role%20of%20opioid%20peptides&rft.jtitle=Domestic%20animal%20endocrinology&rft.au=Chang,%20W.J.&rft.date=1993-10-01&rft.volume=10&rft.issue=4&rft.spage=305&rft.epage=313&rft.pages=305-313&rft.issn=0739-7240&rft.eissn=1879-0054&rft_id=info:doi/10.1016/0739-7240(93)90034-9&rft_dat=%3Cproquest_cross%3E76213387%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76213387&rft_id=info:pmid/8306634&rft_els_id=0739724093900349&rfr_iscdi=true